Company: SUPN
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0001104659-25-042531
Chunk: 8

Company: SUPERNUS PHARMACEUTICALS, INC.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 8
---
4. The Vanguard Group has shared voting and dispositive power with respect to 91,019 and 145,789 shares, respectively, and sole dispositive power with respect to 6,068,942 shares. (3) The number of shares is based on information provided in a Schedule 13G/A filed by Armistice Capital, LLC with the SEC on February 14, 2025. Armistice Capital, LLC and Steven Boyd are the beneficial owners of 4,836,000. Armistice Capital, LLC and Steven Boyd share voting and dispositive power with respect to 4,836,000 shares. (4) The number of shares is based on information provided in a Schedule 13G filed by Dimensional Fund Advisors LP with the SEC on October 31, 2024. (5) The number of shares is based on information provided in a Schedule 13G/A filed jointly by Macquarie Group Limited, Macquarie Management Holdings Inc and Macquarie Investment Management Business Trust with the SEC on February November 1, 2024. Macquarie Group Limited is deemed to have beneficial ownership of 2,631,897 shares due to its ownership of Macquarie Management Holdings Inc. and Macquarie Investment Management Business Trust. Macquarie Management Holdings Inc. is deemed to have beneficial ownership of and sole voting and dispositive power with respect to 2,631,897 shares due to its ownership of Macquarie Investment Management Business Trust. Macquarie Investment Management Business Trust has sole voting and dispositive power with respect to 2,631,897 shares. (6) Includes 1,005,600 shares of common stock held by KBT Trust and 2,019,250 shares of common stock issuable to Mr. Khattar that may be acquired at or within 60 days of April 22, 2025, pursuant to the exercise of outstanding options. (7) Includes 115,000 shares of common stock issuable to Mr. Dec that may be acquired at or within 60 days of April 22, 2025, pursuant to the exercise of outstanding options. (8) Includes 97,750 shares of common stock issuable to Dr. Bhatt that may be acquired at or within 60 days of April 22, 2025, pursuant to the exercise of outstanding options. (9) Includes 75,000 shares of common stock issuable to Dr. Rubin that may be acquired at or within